Literature DB >> 6347574

Prevention of congenital malformations in infants of insulin-dependent diabetic mothers.

K Fuhrmann, H Reiher, K Semmler, F Fischer, M Fischer, E Glöckner.   

Abstract

From April 1977 to April 1981, 420 deliveries of infants of insulin-dependent diabetic women were performed in our department. Of the infants delivered, 23 had congenital malformations (5.5%). The malformation rate was 1.4% for infants of 420 nondiabetic women. Strict metabolic control was begun after 8 wk gestation in 292 of the diabetic women who delivered 22 infants with congenital malformations (7.5%). Intensive treatment was begun before conception in 128 diabetic women planning pregnancy. There was only one malformation in infants of this group (0.8%), a significant reduction from the anomaly rate in the late registrants (X2 = 7.84; P less than 0.01). These observations indicate that reasonable metabolic control started before conception and continued during the first weeks of pregnancy can prevent malformations in infants of diabetic mothers.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347574     DOI: 10.2337/diacare.6.3.219

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  56 in total

Review 1.  Drug-induced congenital defects: strategies to reduce the incidence.

Authors:  M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Protecting the terminus: t-loops and telomere end-binding proteins.

Authors:  C Wei; M Price
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

Review 3.  The utility and efficacy of the new insulins in the management of diabetes and pregnancy.

Authors:  David Simmons
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 4.  Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.

Authors:  S Vijan; D L Stevens; W H Herman; M M Funnell; C J Standiford
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

Review 5.  Management of the pregnant diabetic patient.

Authors:  H W Sutherland; D W Pearson; J K Powrie
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

6.  Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy.

Authors:  K Ylinen; P Aula; U H Stenman; T Kesäniemi-Kuokkanen; K Teramo
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-11

Review 7.  Development of early-onset type 2 diabetes in the young: implications for child bearing.

Authors:  Carol J Homko; E Albert Reece
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

8.  Hemoglobin A1c in pregestational diabetic gravidas and the risk of congenital heart disease in the fetus.

Authors:  Roman Starikov; Justin Bohrer; William Goh; Melissa Kuwahara; Edward K Chien; Vrishali Lopes; Donald Coustan
Journal:  Pediatr Cardiol       Date:  2013-04-26       Impact factor: 1.655

9.  Embryotoxic effects of brief maternal insulin-hypoglycemia during organogenesis in the rat.

Authors:  T A Buchanan; J K Schemmer; N Freinkel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 10.  Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board.

Authors: 
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.